Cargando…
Early Outpatient Treatment for Covid-19 with Convalescent Plasma
BACKGROUND: Polyclonal convalescent plasma may be obtained from donors who have recovered from coronavirus disease 2019 (Covid-19). The efficacy of this plasma in preventing serious complications in outpatients with recent-onset Covid-19 is uncertain. METHODS: In this multicenter, double-blind, rand...
Ejemplares similares
-
Randomized Controlled Trial of Early Outpatient COVID-19 Treatment with High-Titer Convalescent Plasma
por: Sullivan, David J., et al.
Publicado: (2021) -
How do I implement an outpatient program for the administration of convalescent plasma for COVID‐19?
por: Bloch, Evan M., et al.
Publicado: (2022) -
Dynamics of inflammatory responses after SARS-CoV-2 infection by vaccination status in the USA: a prospective cohort study
por: Zhu, Xianming, et al.
Publicado: (2023) -
Randomized controlled trial transfusing convalescent plasma as post-exposure prophylaxis against SARS-CoV-2 infection
por: Shoham, Shmuel, et al.
Publicado: (2021) -
Early Treatment, Inflammation and Post-COVID Conditions
por: Gebo, Kelly A., et al.
Publicado: (2023)